A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
Crossref DOI link: https://doi.org/10.1038/s41392-021-00691-4
Published Online: 2021-07-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Junzhi
Text and Data Mining valid from 2021-07-17
Version of Record valid from 2021-07-17
Article History
Received: 5 May 2021
Revised: 25 May 2021
Accepted: 25 May 2021
First Online: 17 July 2021
Competing interests
: The author declares no competing interests.